Didier Lepelletier

4.2k total citations
145 papers, 2.4k citations indexed

About

Didier Lepelletier is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Didier Lepelletier has authored 145 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Infectious Diseases, 40 papers in Epidemiology and 36 papers in Molecular Medicine. Recurrent topics in Didier Lepelletier's work include Antibiotic Resistance in Bacteria (36 papers), Antimicrobial Resistance in Staphylococcus (28 papers) and Antibiotic Use and Resistance (19 papers). Didier Lepelletier is often cited by papers focused on Antibiotic Resistance in Bacteria (36 papers), Antimicrobial Resistance in Staphylococcus (28 papers) and Antibiotic Use and Resistance (19 papers). Didier Lepelletier collaborates with scholars based in France, United Kingdom and Canada. Didier Lepelletier's co-authors include Stéphane Corvec, Alain Reynaud, Nathalie Caroff, Hervé Richet, Éric Batard, C. Bourigault, J. Caillon, Bruno Grandbastien, Emmanuel Montassier and Bruno Pozzetto and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Didier Lepelletier

140 papers receiving 2.3k citations

Peers

Countries citing papers authored by Didier Lepelletier

Since Specialization

Citations

This map shows the geographic impact of Didier Lepelletier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Lepelletier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Lepelletier more than expected).

Fields of papers citing papers by Didier Lepelletier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Lepelletier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Lepelletier. The network helps show where Didier Lepelletier may publish in the future.

Co-authorship network of co-authors of Didier Lepelletier

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Lepelletier. A scholar is included among the top collaborators of Didier Lepelletier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Lepelletier. Didier Lepelletier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hospital outbreak of NDM-producing Klebsiella pneumoniae in a surgical intensive care unit: Sink traps as the causing source of epidemic strain resurgence 2025 ·American Journal of Infection Control ·C. Bourigault, (unknown), (unknown), Florence Le Gallou, (unknown), Dominique Demeure Dit Latte, Pierre-Joachim Mahé, Gabriel Birgand, (unknown), Karim Asehnoune, Stéphane Corvec, Didier Lepelletier	3
2	Epidemiological and bacteriological trends from 2013 to 2023 of carbapenemase-producing enterobacterales (CPE) in a French university hospital: A permanent risk of outbreak 2024 ·Infectious Diseases Now ·Manon Robert, Stéphane Corvec, (unknown), Florence Le Gallou, (unknown), (unknown), C. Bourigault, Didier Lepelletier	1
3	High-risk clones of Pseudomonas aeruginosa contaminate the drinking water networks of French cities 2024 ·npj Clean Water ·(unknown), (unknown), (unknown), (unknown), Jérôme Ory, (unknown), (unknown), Nadine Lemaître, Matthieu Eveillard, Didier Lepelletier, Xavier Bertrand, Benoı̂t Valot, Didier Hocquet	3
4	Social representations of mask wearing in the general population during the COVID-19 pandemic 2023 ·Frontiers in Public Health ·(unknown), (unknown), Colin Deschanvres, David Boutoille, Jean‐Christophe Lucet, Didier Lepelletier, Brice Leclère, (unknown), Nathan Peiffer‐Smadja, Gabriel Birgand	3
5	SARS-CoV-2 transmission modes: Why and how contamination occurs around shared meals and drinks? 2023 ·Food Microbiology ·Aure Saulnier, (unknown), (unknown), Didier Lepelletier	7
6	New French guidelines to adapt the “Isolate/Detect/Trace” strategy for COVID‐19 adult peoples or contacts considering the exponential spread of Omicron variant 2022 ·Health Science Reports ·Didier Lepelletier, Christian Chidiac, (unknown), Franck Chauvin	1
7	Retrospective analysis of a large single cohort of Enterobacteriaceae producing extended-spectrum B-lactamase (E-ESBL) patients: incidence, microbiology, and mortality 2022 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), (unknown), Florence Le Gallou, Stéphane Corvec, C. Bourigault, Didier Lepelletier	4
8	Management of patients with monkeypox virus infection and contacts in the community and in healthcare settings: a French position paper 2022 ·Clinical Microbiology and Infection ·Didier Lepelletier, Bruno Pozzetto, Franck Chauvin, Christian Chidiac	6
9	Hygienic Perspectives of Wood in Healthcare Buildings 2021 ·SPIRE - Sciences Po Institutional REpository ·Muhammad Tanveer Munir, (unknown), Florence Aviat, Didier Lepelletier, Patrice Le Pape, Laurence Dubreil, Mark Irle, (unknown), (unknown), Michel Fédérighi, Christophe Belloncle	11
10	Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial 2020 ·Trials ·Caroline Trang-Poisson, (unknown), (unknown), Lucie Planche, Harry Sokol, Pascale Bémer, (unknown), (unknown), (unknown), Laurent Flet, Emmanuel Montassier, (unknown), Anne Chiffoleau, (unknown), Didier Lepelletier, J. Caillon, Patrice Le Pape, Berthe‐Marie Imbert, Arnaud Bourreille	3
11	Is unidirectional airflow in operating theater still recommended to reduce surgical site infections? The French point of view through the recent international literature 2019 ·Infection Control and Hospital Epidemiology ·Didier Lepelletier, Bruno Grandbastien, (unknown), Pierre Parneix, (unknown), (unknown), Serge Aho	1
12	Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine–70% isopropanol and 5% povidone iodine–69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery: the CLEAN 2 study protocol 2019 ·BMJ Open ·Matthieu Boisson, Pierre Corbi, Thomas Kerforne, Lionel Camilleri, Mathieu Debauchez, Pierre Demondion, (unknown), Erwan Flécher, Didier Lepelletier, Pascal Leprince, Nicolas Nesseler, (unknown), J Roussel, Bertrand Rozec, Stéphane Ruckly, Jean‐Christophe Lucet, Jean‐François Timsit, Olivier Mimoz	5
13	Knowledge, attitude and behavior of nursing on biomedical waste management quills maternity hospital bonzola reference general/ kasai oriental / ground 2019 ·(unknown), Didier Lepelletier, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stanislas Okitotsho Wembonyama	1
14	Bactéries hautement résistantes aux antibiotiques émergentes et leur prévention 2017 ·Didier Lepelletier	1
15	Hand dermatitis: hand hygiene consequences among healthcare workers 2017 ·Contact Dermatitis ·(unknown), Didier Lepelletier, (unknown), (unknown), C. Bernier	8
16	[The quality assessment of the management of venous catheters]. 2013 ·PubMed ·(unknown), C. Bourigault, (unknown), Didier Lepelletier	2
17	Risk of Highly Resistant Bacteria Importation from Repatriates and Travelers Hospitalized in Foreign Countries: About the French Recommendations to Limit Their Spread 2011 ·Journal of Travel Medicine ·Didier Lepelletier, Antoine Andremont, Bruno Grandbastien, (unknown)	46
18	Who are the carriers of MRSA in the community? A prospective study in the Pays de la Loire region of France 2009 ·Clinical Microbiology and Infection ·(unknown), (unknown), Pierre Lombrail, J. Caillon, G. Potel, (unknown), Didier Lepelletier	5
19	Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients 2006 ·European Journal of Clinical Microbiology & Infectious Diseases ·Didier Lepelletier, Nathalie Caroff, David Riochet, Philippe Bizouarn, A. Bourdeau, Florence Le Gallou, E. Espaze, Alain Reynaud, Hervé Richet	12
20	Surveillance and Control of Methicillin-ResistantStaphylococcus aureusInfections in French Hospitals 2001 ·Infection Control and Hospital Epidemiology ·Didier Lepelletier, Hervé Richet	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact